Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset - HMS LINCS Database

Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>

Cell	Small Molecule	Small Mol Concentration (uM)	Primary Target	Pathway	Mean Normalized Growth Rate Inhibition Value	Increased Fraction Dead
BT-20	Dinaciclib	0.0031623	pan CDK	Cell cycle	1.1052	-0.01052
BT-20	Dinaciclib	0.031623	pan CDK	Cell cycle	-0.2318	0.45734
BT-20	Dinaciclib	0.1	pan CDK	Cell cycle	-0.6475	0.78890
BT-20	Cisplatin	0.0033333	Chemo	Chemotherapy	0.9228	0.00083
BT-20	Cisplatin	0.01	Chemo	Chemotherapy	0.9290	0.00291
BT-20	Cisplatin	0.1	Chemo	Chemotherapy	0.9474	0.00664
BT-20	Cisplatin	0.31623	Chemo	Chemotherapy	0.7633	0.01654
BT-20	Cisplatin	10.0	Chemo	Chemotherapy	-0.3367	0.52833
BT-20	Doxorubicin	0.00031623	Chemo	Chemotherapy	0.9030	-0.00402
BT-20	Doxorubicin	0.0031623	Chemo	Chemotherapy	0.8826	0.01682
BT-20	Doxorubicin	0.01	Chemo	Chemotherapy	0.4333	0.12869
BT-20	Taxol	0.0001	Chemo	Chemotherapy	0.8501	0.01100
BT-20	Taxol	0.00031623	Chemo	Chemotherapy	1.0128	0.00568
BT-20	Taxol	0.0031623	Chemo	Chemotherapy	0.1531	0.33718
BT-20	Taxol	0.01	Chemo	Chemotherapy	-0.4404	0.67612
BT-20	Taxol	0.31623	Chemo	Chemotherapy	-0.5527	0.73180
BT-20	Taxol	1.0	Chemo	Chemotherapy	-0.5760	0.75435
BT-20	Topotecan	0.0033333	Topo I	Chemotherapy	0.8298	0.01267
BT-20	Topotecan	0.01	Topo I	Chemotherapy	0.5944	0.03501
BT-20	Topotecan	1.0	Topo I	Chemotherapy	-0.5883	0.73829
BT-20	Topotecan	3.1623	Topo I	Chemotherapy	-0.6410	0.75823
BT-20	Etoposide	0.0010833	Topo II	Chemotherapy	1.0323	-0.00511
BT-20	Etoposide	0.0033333	Topo II	Chemotherapy	0.9830	-0.00083
BT-20	Cabozantinib	0.01	VEGFR2/MET	RTK	1.0367	0.00057
BT-20	Cabozantinib	0.0031623	VEGFR2/MET	RTK	0.9808	-0.00257